Connect your AI

Boston Scientific BSX Operating Cash Flow

Operating Cash Flow at other companies

AbbottABT

$1.32B-7.2%

TFX

TeleflexTFX

$46.66M+68.3%

Johnson & JohnsonJNJ

$2.51B-39.8%

StrykerSYK

$581M+132%

HaemoneticsHAE

$70.94M-39.1%

CONMEDCNMD

$13.47M-67.6%

Other financials

Income statement

Revenue$5.2B+11.6%

Gross profit$3.6B+12.6%

Operating income$1.1B+19.5%

Net income$1.3B+99.3%

EPS (diluted)$0.90+100%

Balance sheet

Cash & equivalents$850.0M+146%

Total debt$659.0M-94.1%

Total equity$25.9B+16.4%

Total assets$44.4B+10.5%

Cash flow

CapEx$177.0M-5.3%

Free cash flow$171.0M-51.7%

Valuation

Market cap$65.7B-56.2%

P/E18.5×-55.6×

P/S3.2×-5.4×

Profitability

Gross margin69.2%+0.5pp

Operating margin18.4%+2.2pp

Net margin17.3%+5.7pp

FCF margin16.9%-0.3pp

Returns & leverage

Return on equity14.8%+5.2pp

Debt / equity0×-0.5×

Current ratio1.9×+0.4×

Where this comes from

Reported directly by Boston Scientific in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.

The official record: Boston Scientific’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Boston Scientific's operating cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Boston Scientific's operating cash flow?: Boston Scientific (BSX) reported operating cash flow of $348M in Q1 2026.
How has Boston Scientific's operating cash flow changed year-over-year?: Boston Scientific's operating cash flow decreased by 35.7% year-over-year, from $541M to $348M.
What is the long-term trend for Boston Scientific's operating cash flow?: Over 4 years (2021 to 2025), Boston Scientific's operating cash flow has grown at a 24.8% compound annual growth rate (CAGR), from $1.87B to $4.53B.
What does operating cash flow mean?: Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.